[February 15, 2012]

Research and Markets: Australia Diabetes Care Devices Market Outlook to 2017 - Glucose Monitoring and Insulin Delivery

Research and Markets (http://www.researchandmarkets.com/research/0ae5b9/australia_diabetes) has announced the addition of GlobalData's new report "Australia Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery" to their offering.

GlobalData's new report, Australia Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insuln Delivery provides key market data on the Australia Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories - Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope:

• Market size and company share data for Diabetes Care Devices market categories.
• 2010 company shares and distribution shares data for each of the two market categories.
• Global corporate-level profiles of key companies operating within the Australia Diabetes Care Devicesmarket.
• Key players covered include F. Hoffmann-La Roche Ltd., Novo Nordisk A/S, Sanofi, Medtronic, Inc., Abbott Laboratories, Bayer HealthCare AG and others.

Reasons to Buy:

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the Australia Diabetes Care Devices competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

Companies Mentioned:

• ARKRAY, Inc.
• Abbott Laboratories
• Animas Corporation
• B. Braun Melsungen AG
• Bayer HealthCare AG
• Becton, Dickinson and Company
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd.
• Medtronic, Inc.
• NIPRO CORPORATION
• Novo Nordisk A/S
• Sanofi

For more information visit http://www.researchandmarkets.com/research/0ae5b9/australia_diabetes

[ Back To TMCnet.com's Homepage ]